Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum

Nicotine and Tobacco Research

Volumn 13, Issue 7, 2011, Pages 573-578

  Lunell, Erik ^a   Curvall, Margareta ^b  

^a CROel AB   (Sweden)

^b Swedish Match AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE GUM;

ADULT; AREA UNDER THE CURVE; ARTICLE; BURNING SENSATION; CIGARETTE SMOKING; CLINICAL ARTICLE; COUGHING; CROSSOVER PROCEDURE; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HICCUP; HUMAN; MALE; NAUSEA; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVATION; SMOKELESS TOBACCO; SMOKING CESSATION; SWEDEN; VISUAL ANALOG SCALE;

EID: 79960192032     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr044     Document Type: Article

References (28)

1. Andersson, G. (1991). Snuff-induced changes associated with the use of loose and portion-bag-packed Swedish moist snuff-A clinical, histological and follow-up study. Swedish Dental Journal Supplement, 75, 1-55.
2. Andersson, G., Bjornberg, G., & Curvall, M. (1994). Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: A comparative study. Journal of Oral Pathology & Medicine, 23, 161-167. doi:10.1111/j.1600-0714.1994.tb01106.x.
3. Benowitz, N. L., Porchet, H., Sheiner, L., & Jacob, P. (1988). Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clinical Pharmacology and Therapeutics, 44, 23-28. doi:10.1038/clpt.1988.107.
4. Blank, M. D., & Eissenberg, T. (2010). Evaluating oral noncombustible potential-reduced exposure products for smokers. Nicotine & Tobacco Research, 12, 336-343. doi:10.1093/ntr/ntq003.
5. Breland, A. B., Kleykamp, B. A., & Eissenberg, T. (2006). Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine & Tobacco Research, 8, 727-738. doi:10.1080/14622200600789585.
6. Caldwell, B., Burgess, C., & Crane, J. (2010). Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers. Nicotine & Tobacco Research, 12, 179-183. doi:10.1093/ntr/ntp189.
7. Christen, A. G., Young, J. M., Beiswanger, B. B., Jackson, R. D., & Potter, R. H. (1989). Effects of nicotine chewing gum on complete dentures and their soft-tissue-bearing areas. International Journal of Prosthodontics, 2, 155-162.
8. Cobb, C. O., Weaver, M. F., & Eissenberg, T. (2010). Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers. Tobacco Control, 19, 367-373. doi:10.1136/tc.2008.028993.
9. CORESTA Recommended Method No 62 (2005). Determination of nicotine in tobacco and tobacco products by gas chromatographic analysis. Retrieved from http://www.coresta.org.
10. Eliasson, M., Asplund, K., Nasic, S., & Rodu, B. (2004). Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: The northern Sweden MONICA study. Journal of Internal Medicine, 256, 101-110. doi:10.1111/j.1365-2796.2004.01344x.
11. Fant, R. V., Henningfield, J., Nelson, R. A., & Pickworth, W. B. (1999). Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tobacco Control, 8, 387-392. doi:10.1136/tc.8.4.387.
12. Feyerabend, C. (1990). Determination of nicotine and cotinine in human plasma. Journal of Pharmacy and Pharmacology, 42, 450-452.
13. Foulds, J., Ramstrom, L., Burke, M., & Fagerstrom, K. (2003). Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control, 12, 349-359. doi:10.1136/tc.12.4.349.
14. Gilljam, H., & Galanti, M. R. (2003). Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction, 9, 1183-1189. doi:10.1046/j.1360-0443.2003.00379x.
15. Hansson, J., Pedersen, N. L., Galanti, M. R., Andersson, T., Ahlbom, A., Hallqvist, J., et al. (2009). Use of snus and risk for cardiovascular disease: Results from the Swedish Twin Registry. Journal of Internal Medicine, 265, 717-724. doi:10.1111/j.1365-2796-2009.02081x.
16. Hatsukami, D. K., Lemmonds, C., & Tomar, S. L. (2004). Smokeless tobacco use: Harm reduction or induction approach? Preventive Medicine, 38, 309-317. doi:10.1016/j.ypmed.2003.10.006.
17. Henningfield, J. E., & Keenan, R. (1993). Nicotine delivery kinetics and abuse liability. Journal of Consulting and Clinical Psychology, 61, 743-750.
18. Henningfield, J. E., Radzius, A., Cooper, T. M., & Clayton, R. R. (1990). Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. Journal of American Medical Association, 264, 1560-1564.
19. Kozlowski, L. T., O'Connor, R. J., Edwards, B. F., & Flaherty, B. F. (2003). Most smokeless tobacco is not a causal gateway to cigarettes: Using order of use to evaluate causation in a national U.S. sample. Addiction, 98, 1077-1085.
20. Lunell, E., & Lunell, M. (2005). Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 4 mg nicotine polacrilex chewing gum. A cross-over study. Nicotine & Tobacco Research, 7, 397-403. doi:10.1080/14622200500125468.
21. Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H-O, Boffetta, P., et al. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: A retrospective cohort study. Lancet, 369, 2015-2020. doi:10-1016/50140-6736(07)60677-1.
22. Niaura, R., Sayette, M., Shiffman, S., Glover, E. D., Nides, M., Shelanski, M., et al. (2005). Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction, 100, 1720-1730. doi:10.1111/j.1360-0443.2005.01218x.
23. Persson, P-G, Carlsson, S., Svanström, L., Östenson, C-G, Efendic, S., & Grill, V. (2000). Cigarette smoking, oral moist snuff use and glucose intolerance. Journal of Internal Medicine, 248, 103-110. doi:10-1046/j.1365-2796.2000.00708.x.
24. Ramström, L. M., & Foulds, J. (2006). Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control, 15, 210-214. doi:10.1136/tc.2005.014969.
25. Rodu, B. (2007). Snus and risk of cancer of the mouth, lung and pancreas. Lancet, 370, 1207-1208. author reply 1208. doi:S0140-6736(07)61533-5[pii]10.1016/S0140-6736(07)61533-5.
26. Roosaar, A., Johansson, A. L. V., Sandborg-Englund, G., Axéll, T., & Nyrén, O. (2008). Cancer and mortality among users and nonusers of snus. International Journal of Cancer, 123, 168-173. doi:10.1002/ije.23469.
27. Summary of product characteristics Nicorette 4 mg gum, Pfizer (2011). Retrieved from www.Medicines.org.uk.
28. Thornley, S., McRobbie, H., Lin, R. B., Bullen, C., Hajek, P., Laugesen, M., et al. (2009). A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction. Nicotine & Tobacco Research, 11, 715-721. doi:10.1093/ntr/ntp054.